Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Covered self-expandable metal stents for distal biliary obstruction from pancreatic carcinoma: what type of stent is preferred?

  • Hideyuki Shiomi (Division of Gastroenterology and Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo Medical University) ;
  • Ryota Nakano (Division of Gastroenterology and Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo Medical University) ;
  • Shogo Ota (Division of Gastroenterology and Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo Medical University)
  • Received : 2022.04.06
  • Accepted : 2022.04.13
  • Published : 2022.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

Acknowledgement

This work was supported by JSPS KAKENHI (Grants-in-Aid for Scientific Research), Grant no. 21K07913 (HS).

References

  1. Moss AC, Morris E, Leyden J, et al. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol 2007;19:1119-1124. https://doi.org/10.1097/MEG.0b013e3282f16206
  2. Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 2004;53:729-734. https://doi.org/10.1136/gut.2003.018945
  3. Kitano M, Yamashita Y, Tanaka K, et al. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial. Am J Gastroenterol 2013;108:1713-1722. https://doi.org/10.1038/ajg.2013.305
  4. Telford JJ, Carr-Locke DL, Baron TH, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc 2010;72:907-914. https://doi.org/10.1016/j.gie.2010.08.021
  5. Kullman E, Frozanpor F, Soderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc 2010;72:915-923. https://doi.org/10.1016/j.gie.2010.07.036
  6. Kitagawa K, Mitoro A, Ozutsumi T, et al. Laser-cut-type versus braided-type covered self-expandable metallic stents for distal biliary obstruction caused by pancreatic carcinoma: a retrospective comparative cohort study. Clin Endosc 2022;55:434-442. https://doi.org/10.5946/ce.2021.161
  7. Kogure H, Ryozawa S, Maetani I, et al. A prospective multicenter study of a fully covered metal stent in patients with distal malignant biliary obstruction: WATCH-2 study. Dig Dis Sci 2018;63:2466-2473. https://doi.org/10.1007/s10620-017-4875-5
  8. Isayama H, Kawakubo K, Nakai Y, et al. A novel, fully covered laser-cut nitinol stent with antimigration properties for nonresectable distal malignant biliary obstruction: a multicenter feasibility study. Gut Liver 2013;7:725-730. https://doi.org/10.5009/gnl.2013.7.6.725
  9. Yamao K, Takenaka M, Ogura T, et al. Utility and safety of a novel fully covered metal stent in unresectable distal malignant biliary obstruction. Dig Dis Sci 2020;65:3702-3709. https://doi.org/10.1007/s10620-020-06114-8
  10. Nakai Y, Isayama H, Kogure H, et al. Risk factors for covered metallic stent migration in patients with distal malignant biliary obstruction due to pancreatic cancer. J Gastroenterol Hepatol 2014;29:1744-1749. https://doi.org/10.1111/jgh.12602